Esperion Therapeutics | Kortsiktig Gjeld

Current Liabilities Endring Dato
AbbVie USD 34.77B 2.53B 2023-09
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
Amgen USD 18.39B 1.44B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
CSL USD 4.61B 278.2M 2023-06
Cytokinetics USD 102.68M 24.96M 2023-12
Daiichi Sankyo JPY 532.25B 19.14B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Geron USD 108.07M 18.68M 2023-12
Grifols EUR 2.03B 148.07M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Pfizer USD 31.14B 3.51B 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
United Therapeutics USD 804.4M 60.3M 2023-12



Esperion Therapeutics Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.